Ultragenyx Pharmaceutical, Inc. (RARE)
22.49
-1.01
(-4.30%)
USD |
NASDAQ |
Jan 16, 16:00
22.59
+0.10
(+0.44%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Shareholders Equity (Annual): 255.30M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Corcept Therapeutics, Inc. | 679.59M |
| Johnson & Johnson | 71.49B |
| CorMedix, Inc. | 84.66M |
| Amicus Therapeutics, Inc. | 194.04M |
| Geron Corp. | 280.32M |